NICE guidance (TA875) specifies that semaglutide for weight management should only be prescribed as part of a specialist weight management service, which typically includes access to dietitians, psychologists, and specialist physicians or nurses
doi: 10.1016/j.jacc.2013.11.004 24 GarveyWTMechanickJIBrettEMGarberAJHurleyDLJastreboffAMet al
FDA-registered 503B facilities are listed publicly on the FDA website under Outsourcing Facilitiescross-reference the facility name on your shipment against that list
Common side effects include nausea, vomiting, diarrhea, and constipation, typically mild and transient during dose escalation
GLP-1 medications provide an added boost by curbing appetite, reducing cravings, and making it easier to stay on track without feeling deprived
We advise you to read labels and directions.